Almirall Logo
  • About Us
  • Therapeutic Focus
  • Prescription Medicines
  • Helpful Resources

    • Select your Almirall

    • WorldWide
    • France
    • Germany
    • Italy
    • Netherlands
    • Poland
    • Spain
    • Spain (Catalá)
    • Austria
    • Switzerland
    • United Kingdom
    • Czechia
    • Slovakia
    • Nordics
  • Careers
  • Investors

View all results

Back to newsroom

Almirall U.S. Supports The Skin Cancer Foundation’s Mobile Skin Cancer Screening Program

08 November 2021
  • The Foundation’s Destination Healthy Skin RV visits communities around the U.S. to raise skin cancer awareness

Resources

  • Download news   PDF (326KB)

Back to newsroom

25 May 2023

Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer

24 May 2023

85% of people unaware of actinic keratosis, the most common pre-cancerous skin condition

08 May 2023

Almirall’s First Quarter 2023 Results: Almirall's Net Sales reach € 232MM and increase by 6%, boosted by a solid European dermatology business

View all press

Logo footer
  • Contact Us
  • News
  • Social Responsibility
  • Terms of Use
  • Privacy Policy
  • Cookies Policy

Contents © 2005-2022 Almirall, LLC, Malvern, PA 19355. All Rights Reserved.

Facebook Instagram Linkedin Twitter

By clicking on the link below, you acknowledge that you are leaving the Almirall, LLC - U.S. website.

Would you like to continue?

No

Yes

By clicking on the link below, you acknowledge that you are leaving the Almirall, LLC - U.S. website.

Would you like to continue?

No

Yes

The content you are about to see is restricted to media professional use

Please let us know if you are a professional to continue.

Cancel

I'm a media professional

Your browser is not compatible with our website.

The version of Internet Explorer you are using is outdated. To have a complete user experience in almirall.com, we recommend you to update your browser or enter from the latest versions of Edge, Chrome, Safari, Opera or Firefox.

OK